Chou Associates Management TEVA-OLD trades
Francis Chou
Francis Chou Teva Pharma Industries Ltd ADR stake
total: 81
Trades details
- Total transactions:
- 4
- New positions:
- 1
- Sold out:
- 1
- Added:
- 1
- Reduced:
- 1
- Held since:
- 2017 Q1
- Held for:
- 11 quarters
- Latest activity:
- 2019 Q4
According to 2026 Q2 report, Francis Chou doesn't hold any Teva Pharma Industries Ltd ADR (TEVA-OLD) shares. To date, the estimated cost basis is nearly $32.81 for "buy" trades and estimated average "sell" price is $18.58. Chou Associates Management first purchased TEVA-OLD in 2017 Q1, initially acquiring 215,000 shares. Since the initial investment in Teva Pharma Industries Ltd ADR (TEVA-OLD), Chou Associates Management has made 3 more transactions.
When did Francis Chou sell Teva Pharma Industries Ltd ADR (TEVA-OLD)?
Francis Chou sold off the entire Teva Pharma Industries Ltd ADR (TEVA-OLD) position in 2019 Q4.
When did Francis Chou buy Teva Pharma Industries Ltd ADR (TEVA-OLD)?
Francis Chou first invested in Teva Pharma Industries Ltd ADR (TEVA-OLD) in 2017 Q1 at the reported quarter-end price of $32.09 per share.
What's the cost basis of Chou Associates Management's TEVA-OLD stake?
The estimated cost basis for Teva Pharma Industries Ltd ADR (TEVA-OLD) stake is around $32.81 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $32.81
- Weighted AVG sell price:
- $18.58
Francis Chou's historical trades in Teva Pharma Industries Ltd ADR
4 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2019 Q4
|
0.00%
|
$6.87
|
-100% (-15,000)
|
|||
|
2017 Q4
|
0.12%
|
$18.93
|
-97.03% (-490,000)
|
|||
|
2017 Q2
|
5.20%
|
$33.34
|
+134.88% (+290,000)
|
|||
|
2017 Q1
|
2.29%
|
$32.09
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.